Drug hypersensitivity syndrome;Syndrome d'hypersensibilite medicamenteuse

Nouvelles Dermatologiques

Volumn 16, Issue 4, 1997, Pages

  Antunes, A ^a,b   Davril, A ^a,b   Moussa, G ^a,b   Granel, F ^a,b   Trechot, P ^a,b   Truchetet, F ^a,b   Cuny, J F ^a,b  

^a Bon Secours Hospital   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

carbamazepine; drug hypersensitivity syndrome

Indexed keywords

ALLOPURINOL; ANTICONVULSIVE AGENT; CARBAMAZEPINE; DAPSONE; ETHAMBUTOL; GOLD SALT; MINOCYCLINE; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION;

EID: 0004746425     PISSN: 07525370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Begaud B., Evreux JC., Jouglard J., Logier G. Imputabilité des effets inattendus ou toxiques des médicaments. Thérapie 1985; 40: 111-118.
2. Truchetet F., Grosshans E., Brandenburger M. Les tests cutanés dans l'allergie médicamenteuse endogène. Ann. Dermatol. Vénéréol. 1987; 114: 989-997.
3. Bonnetblanc J.M. Drug hypersensitivity syndrome. Dermatology 1993; 187: 84-85.
4. Roujeau JC., Stern RS. Severe adverse cutaneous reactions to drugs. N. Engl. J. Med. 1994; 331: 1272-1285.
5. Roberts DL, Marks R. Skin reactions to carbamazepine. Arch. Dermatol. 1981; 117: 273-275.
6. Kleier RS., Breneman DL., Boiko S. Generalized pustulation as manifestation of the anticonvulsivant hypersensitivity syndrome. Arch. Dermatol. 1991; 127: 1361-1364.
7. Sheretz EF., Jegasothy BV., Lazarus GS. Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. J. Am. Acad. Dermatol. 1985; 12: 178-181.
8. Handfield-Jones SE., Jenkins RE., Whittaker SJ., Besse CP., et al. The anticonvulsivant hypersensitivity syndrome. Br. J. Dermatol. 1993; 129: 175-177.
9. Wolkenstein P., Roujeau JC. Toxidermies. Encycl. Mêd. Chir., Dermatologie 1995; 12-930-A-10: 7 p.
10. Silverman AK., Fairley J., Wong RC. Cutaneous and immulogic reactions to phenytoin. J. Am. Acad. Dermatol. 1988; 18: 721-741.
11. Braddock SW., Harrington D., Vose J. Generalized nodular cutaneous pseudolymphoma associeted with phenytoin therapy. J. Am. Acad. Dermatol. 1992; 27: 337-340.
12. Shear NH., Spielberg ST. Anticonvulsivant hypersensitivity syndrome. In vitro assessment of risk. J. Clin. Invest. 1988 ; 82: 1826-32.
13. Alldredge BK., Knutsen AP., Ferreiro D. Antiepileptic drug hypersensitivity syndrome: in vitro and clinical observations. Pediatr. Neurol. 1994; 10: 169-171.
14. Bocquet H., Bourgault-Villada I., Delfau-Larue MH., Wechsler J. et al. Syndrome d'hypersensibilité à la dapsone. Clone T circulant transitoire. Ann. Dermatol. Vénéréol. 1995; 122: 514-516.
15. Dussopt C., Mornex JF., Cordier JF., Brune J Poumon éosinophile aigu après prise de minocycline. Rev. Mal. Resp. 1994; 11: 67-70.
16. Parneix-Spake A., Bastuji-Garin S., Lobut JB., Erner J et al. Minocycline as possible cause of severe and protracted hypersensibility drug reaction. Arch. Dermatol. 1995; 131: 490-491.
17. Jones M., Fernandez Herrera J., Dorado J.M., Sols M. et al. Epicutaneous test in carbamazepine cutaneous reactions. Dermatology 1994; 188: 18-20.
18. Calkin JM., Maibach HI. Delayed hypersensitivity drug reactions diagnosed by patch testing. Contact Dermatitis 1993; 29: 223-233.